uracil has been researched along with Dyslipidemia in 2 studies
2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder
| Excerpt | Relevance | Reference |
|---|---|---|
| " 3,5-diiodothyronine (T2) has been used with success in rat models of dyslipidemia and NAFLD, but the outcome of a clinical trial with a synthetic T2 analogue was disappointing." | 5.05 | Thyroid Hormone Analogues: An Update. ( Zucchi, R, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zucchi, R | 1 |
| Kelly, MJ | 1 |
| Pietranico-Cole, S | 1 |
| Larigan, JD | 1 |
| Haynes, NE | 1 |
| Reynolds, CH | 1 |
| Scott, N | 1 |
| Vermeulen, J | 1 |
| Dvorozniak, M | 1 |
| Conde-Knape, K | 1 |
| Huang, KS | 1 |
| So, SS | 1 |
| Thakkar, K | 1 |
| Qian, Y | 1 |
| Banner, B | 1 |
| Mennona, F | 1 |
| Danzi, S | 1 |
| Klein, I | 1 |
| Taub, R | 1 |
| Tilley, J | 1 |
1 review available for uracil and Dyslipidemia
| Article | Year |
|---|---|
Thyroid Hormone Analogues: An Update.
Topics: Acetates; Anilides; Animals; Central Nervous System Diseases; Clinical Trials as Topic; Diiodothyron | 2020 |
1 other study available for uracil and Dyslipidemia
| Article | Year |
|---|---|
Discovery of 2-[3,5-dichloro-4-(5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yloxy)phenyl]-3,5-dioxo-2,3,4,5-tetrahydro[1,2,4]triazine-6-carbonitrile (MGL-3196), a Highly Selective Thyroid Hormone Receptor β agonist in clinical trials for the treatment of dys
Topics: Animals; Bone Density; Clinical Trials as Topic; Drug Discovery; Dyslipidemias; Humans; Male; Mice; | 2014 |